With the addition of 0.5 mM GSH (P1), 88 vitrified oocytes resulted in 56 oocytes surviving (63.96.7)%, 8 with zona pellucida fractures (8.02.0)%, 16 with cytoplasmic shrinkage (16.54.0)%, and 11 with cytoplasmic lysis (11.74.7)%
The microdose plan lands around $199 a month after the promo, billed as $597 every 12 weeks
The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk
Boosting proprioceptive input through good posture and spinal function is critical for healthy brain development